Kelvin D J, Simard G, Sue-A-Quan A, Connolly J A
Department of Anatomy, University of Toronto, Canada.
J Cell Biol. 1989 Jan;108(1):169-76. doi: 10.1083/jcb.108.1.169.
In the preceding report (Kelvin, D.J., G. Simard, H.H. Tai, T.P. Yamaguchi, and J.A. Connolly. 1989. J. Cell Biol. 108:159-167) we demonstrated that pertussis toxin (PT) blocked proliferation and induced differentiation in BC3H1 muscle cells. In the present study, we have used PT to examine specific growth factor signaling pathways that may regulate these processes. Inhibition of [3H]thymidine by PT in 20% FBS was reversed in a dose-dependent fashion by purified fibroblast growth factor (FGF). In 0.5% FBS, the normally induced increase in creatine kinase (CK) activity was blocked by FGF in both the presence and absence of PT. Similar results were obtained with purified epidermal growth factor (EGF). We subsequently examined the effect of a family of growth factors linked to inositol lipid hydrolysis and found that thrombin, like FGF, would increase [3H]thymidine incorporation and block CK synthesis. However, PT blocked thymidine incorporation induced by thrombin, and blocked the inhibition of CK turn-on in 0.5% FBS by thrombin. The ras oncogene, a G protein homologue, has previously been shown to block muscle cell differentiation in C2 muscle cells (Olson, E.N., G. Spizz, and M.A. Tainsky. 1987. Mol. Cell. Biol. 7:2104-2111); we have characterized a BC3H1 cell line, BCT31, which we transfected with the val12 oncogenic Harvey ras gene. This cell line did not express CK in response to serum deprivation. Whereas [3H]thymidine incorporation was inhibited by 70-80% by increasing doses of PT in control cells, BCT31 cells were only inhibited by 15-20%. ADP ribosylation studies indicate this PT-insensitivity is not because of the lack of a PT substrate in this cell line. Furthermore, PT could not induce CK expression in BCT31 cells as it did in parental cells. We conclude that there are at least two distinct growth factor pathways that play a key role in regulating proliferation and differentiation in BC3H1 muscle cells, one of which is PT sensitive, and postulate that a G protein is involved in transducing signals from the thrombin receptor. We believe that ras functions in the transduction of growth factor signals in the nonPT-sensitive pathway or downstream from the PT substrate in the second pathway.
在之前的报告中(凯尔文,D.J.,G. 西马尔德,H.H. 泰,T.P. 山口,以及 J.A. 康诺利。1989 年。《细胞生物学杂志》108 卷:159 - 167 页),我们证明百日咳毒素(PT)可阻断 BC3H1 肌肉细胞的增殖并诱导其分化。在本研究中,我们使用 PT 来检测可能调节这些过程的特定生长因子信号通路。在 20%胎牛血清(FBS)中,PT 对[³H]胸腺嘧啶核苷掺入的抑制作用可被纯化的成纤维细胞生长因子(FGF)以剂量依赖的方式逆转。在 0.5% FBS 中,无论有无 PT,正常诱导的肌酸激酶(CK)活性增加均被 FGF 阻断。纯化的表皮生长因子(EGF)也得到了类似结果。随后,我们检测了与肌醇脂质水解相关的一族生长因子的作用,发现凝血酶与 FGF一样,可增加[³H]胸腺嘧啶核苷掺入并阻断 CK 合成。然而,PT 可阻断凝血酶诱导的胸腺嘧啶核苷掺入,并阻断凝血酶对 0.5% FBS 中 CK 开启的抑制作用。癌基因 ras 是一种 G 蛋白同源物,先前已证明它可阻断 C2 肌肉细胞的分化(奥尔森,E.N.,G. 斯皮兹,以及 M.A. 坦斯基。1987 年。《分子与细胞生物学》7 卷:2104 - 2111 页);我们鉴定了一个 BC3H1 细胞系 BCT31,我们用致癌的 Harvey ras 基因 val12 转染了该细胞系。该细胞系在血清剥夺时不表达 CK。在对照细胞中,随着 PT 剂量增加,[³H]胸腺嘧啶核苷掺入被抑制 70 - 80%,而 BCT31 细胞仅被抑制 15 - 20%。ADP 核糖基化研究表明,这种对 PT 的不敏感性并非由于该细胞系中缺乏 PT 底物。此外,PT 不能像在亲代细胞中那样诱导 BCT31 细胞表达 CK。我们得出结论,至少有两条不同的生长因子通路在调节 BC H1 肌肉细胞的增殖和分化中起关键作用,其中一条对 PT 敏感,并推测一种 G 蛋白参与从凝血酶受体转导信号。我们认为 ras 在非 PT 敏感通路的生长因子信号转导中起作用,或在第二条通路中 PT 底物的下游起作用。